Nexeon Medsystems Inc Stock

Equities

NXNN

US65342G2030

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 10:06:42 2023-09-14 EDT 5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Nexeon Medsystems Inc -.--% -.--%
Sales 2016 - Sales 2017 3.3 4.55 Capitalization 49.02M 67.5M
Net income 2016 -1M -1.38M Net income 2017 -2M -2.75M EV / Sales 2016 * -
Net cash position 2016 2.01M 2.77M Net Debt 2017 3.33M 4.59M EV / Sales 2017 15,849,303 x
P/E ratio 2016 *
-
P/E ratio 2017
-20.5 x
Employees 62
Yield 2016 *
-
Yield 2017
-
Free-Float 49.16%
More Fundamentals * Assessed data
Dynamic Chart
Nexeon Medsystems Inc. Announces Resignation of Miro Zecevic as Member of the Board of Directors CI
Nexeon Medsystems Inc. Announces the Resignation of Wes Ditmer as A Member of the Board of Directors CI
Nexeon Medsystems Inc. Reports Consolidated Earnings Results for the Third Quarter Ended September 30, 2018 CI
Nexeon MedSystems Receives Grant Matching Funds from the Puerto Rico Science, Technology, and Research Trust CI
Nexeon MedSystems Inc. Announces Resignation of Brian Blischak as President and Chief Commercial Officer CI
Nexeon MedSystems Inc. Reports Consolidated Earnings Results for the Second Quarter Ended June 30, 2018 CI
Nexeon MedSystems Inc. will Change its Ticker to NXNN from NXNND CI
Nexeon MedSystems Inc. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2018 CI
Nexeon Medsystems Inc Announces Board Changes CI
Nexeon MedSystems Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017 CI
Nexeon MedSystems Inc. Auditor Raises 'Going Concern' Doubt CI
Nexeon MedSystems Inc. Announces Board Changes CI
Nexeon MedSystems Inc. Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator CI
Nexeon MedSystems Inc. announced that it expects to receive $1 million in funding from Leonite Capital LLC CI
Nexeon MedSystems Inc. announced that it has received $1.17 million in funding CI
More news
1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0.0001
0.95
5 years
0.00
Extreme 0
5.50
10 years
0.00
Extreme 0
35.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 55 15-11-30
Sales & Marketing 48 17-06-25
Members of the board TitleAgeSince
Director/Board Member 44 16-12-31
Director/Board Member 63 16-12-31
More insiders
Nexeon MedSystems Inc is a medical device development and manufacturing company. It is focused on providing neurostimulation products designed to improve the quality of life of patients suffering from debilitating neurological diseases. Its primary purposes are to develop and commercialize its neurostimulation technology platform for the treatment of various disorders via electrical stimulation of tissues associated with the nervous system. Its operations include operations of its subsidiaries, which include Nexeon MedSystems Europe, SARL (Nexeon Europe), Nexeon MedSystems Puerto Rico Operating Company Corporation (NXPROC), NMB (which owns and operates Medi-Line), SA, and Pulsus Medical, LLC (Pulsus). Nexeon Europe is the holding company for NXPROC and NMB. NXPROC is focused on advanced computational biology and deep learning utilization associated with the Internet of Medical Things technology. Pulsus conducts research and development related to cardiovascular disease technology.
More about the company